FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_S_5167.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2022-12-01.
What are the main provisions?
Key points include:
- Temporary controls on fentanyl-related substances are extended for two years after the date of enactment.
- The Attorney General must create synthetic compounds of encountered substances for scientific evaluation by the Secretary of Health and Human Services.
- Substances may be removed from Schedule I or rescheduled to Schedule III, IV, or V based on evaluations of their abuse potential.
- The Attorney General is required to notify individuals with pending prosecutions or convictions involving a substance that is subsequently removed or rescheduled.
- $50 million is authorized for fiscal years 2023 and 2024 for the evaluation of fentanyl-related substances.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Booker, Cory A. [D-NJ].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.
What is the impact of this bill?
We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.